Billy reacts to Miley dropping her last namePublished on: September 6, 2026 10:01 AM

Pakistan, Sept. 6 -- Billy Ray Cyrus is letting his butterfly fly away. After Miley Cyrus dropped her surname to debut her forthcoming Bass Persuades album, out Sept. 18, her dad shared his reaction. ... Read More

Fake Florida doctor dupes retired teacher of rRs.r70K, she loses rRs.r14L in refund bid

India, Sept. 6 -- A 70-year-old retired teacher who lost Rs.70,000 to a man posing as a Florida-based doctor was cheated of another Rs.14.38 lakh when she went online seeking help to recover her money... Read More

Aja Ekadashi 2026 Date: When Is Aja Ekadashi? Check Vrat Date, Ekadashi Tithi, Parana Time, Puja Vidhi, Fasting Rules & Significance

India, Sept. 6 -- Aja Ekadashi, dedicated to Lord Vishnu, will be observed on Monday, September 7, 2026. According to the New Delhi-based Panchang calculation, the Ekadashi Tithi begins on September 6... Read More

Acidity vs GERD: What's the difference? Doctors explain symptoms, causes and treatment

New Delhi, Sept. 6 -- Acidity, acid reflux and GERD are terms often used interchangeably, but they do not necessarily mean the same thing. While occasional heartburn or acid reflux can be common, freq... Read More

DU colleges open doors to anguished students of nearby PGs after building collapse in Satya Niketan

India, Sept. 6 -- Following the tragic building collapse of a PG hostel building in Delhi's Satya Niketan, several colleges of the Delhi University have opened doors to the students of the nearby PGs.... Read More

Galaxy S26 Ultra vs iPhone 17 Pro Max: Which one should you choose?

India, Sept. 6 -- Once, choosing between the best flagships in India was a straightforward affair based on the operating system. But Samsung's price cut and special exchange offers on the Galaxy S26 U... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Sept. 6 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

• ««
• «
• 1727
• 1728
• 1729
• 1730
• 1731
• 1732
• 1733
• 1734
• 1735
• 1736
• »
• »»